To date, there have been 35 Pre-IND meeting requests for proposed biosimilars to 11 reference products. 21 PRE IND sponsor meetings held, and 9 INDs received.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”